Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-06

Clinical Trial Update: Lactobacillus Johnsonii in Children and Adolescents With T1D [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the safety and potential efficacy of Lactobacillus johnsonii in children and adolescents with Type 1 diabetes mellitus, complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus Johnsonii (Lactobacillus Johnsonii)

Snippet

Sponsor: University of Florida | Conditions: Type 1 Diabetes (T1D) | Phase 2 | Status: COMPLETED